Tecnimede Group is a Portuguese multinational company, with more than 40 years of history in the life cycle of the drug product for human use - development, production and marketing - with the mission to improve
This role is strictly on-site in Lisbon, Portugal. Only applicants who are already residents of Portugal will be considered. The Opportunity Are you ready to advance your professional path in Europes sunniest capital? We are searching
Location: Fully On-site (Lisbon Headquarters) Sector: International Digital Payments & Financial Technology Shift Structure: 24/7 Rotating Roster (Includes evening and weekend shifts) Begin a rewarding career path within the rapidly expanding financial technology market! We are
The Tecnimede Group has 750 employees around the world looking to the future, united and focused on improving and preserving the health of us all. Because we control the entire life cycle of medicines for human
At Tecnimede Group, we are driven by a clear purpose: improving peoples lives through medical science and technology. As a Portuguese multinational pharmaceutical company with a presence in six countries and products reaching more than 100
At Tecnimede Group, we are driven by a clear purpose: improving peoples lives through medical science and technology. As a Portuguese multinational pharmaceutical company with a presence in six countries and products reaching more than 100
Tecnimede Group is a 40 years Portuguese multinational company that wants to improve and preserve human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological
At Tecnimede Group, we are driven by a clear purpose: improving peoples lives through medical science and technology. As a Portuguese multinational pharmaceutical company with a presence in six countries and products reaching more than 100
The Tecnimede Group has 900 employees around the world looking to the future, united and focused on improving and preserving the health of all of us. Because we own the entire life cycle of medicines for